White Water Investment

Whitewater Bioventures is a life science venture capital firm and incubator that focuses on the creation and early-stage development of biotechnology companies. Founded by industry veterans, including renowned scientist and entrepreneur Richard DiMarchi, the firm specializes in identifying high-potential therapeutic technologies and providing the necessary capital and management expertise to bring them to fruition. Whitewater Bioventures is particularly known for its success in the metabolic disease space, having played a pivotal role in the formation of companies such as Marcadia Biotech, Calibrium, and MB2, all of which were subsequently acquired by major pharmaceutical companies. The firm operates primarily as a company builder, leveraging its deep scientific network to translate academic research into clinical-stage assets.